| Literature DB >> 19144146 |
Harun M Said1, Buelent Polat, Carsten Hagemann, Jelena Anacker, Michael Flentje, Dirk Vordermark.
Abstract
BACKGROUND: Gene expression studies related to cancer diagnosis and treatment are important. In order to conduct such experiment accurately, absolutely reliable housekeeping genes are essential to normalize cancer related gene expression. The most important characteristics of such genes are their presence in all cells and their expression levels remain relatively constant under different experimental conditions. However, no single gene of this group of genes manifests always stable expression levels under all experimental conditions. Incorrect choice of housekeeping genes leads to interpretation errors of experimental results including evaluation and quantification of pathological gene expression. Here, we examined (a) the degree of GAPDH expression regulation in Hep-1-6 mouse hepatoma and Hep-3-B and HepG2 human hepatocellular carcinoma cell lines as well as in human lung adenocarcinoma epithelial cell line (A-549) in addition to both HT-29, and HCT-116 colon cancer cell lines, under hypoxic conditions in vitro in comparison to other housekeeping genes like beta-actin, serving as experimental loading controls, (b) the potential use of GAPDH as a target for tumor therapeutic approaches was comparatively examined in vitro on both protein and mRNA level, by western blot and semi quantitative RT-PCR, respectively.Entities:
Year: 2009 PMID: 19144146 PMCID: PMC2646737 DOI: 10.1186/1756-0500-2-8
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Figure 1GAPDH mRNA and protein expression under extreme hypoxic (0.1% O. (A) Semiquantitative RT-PCR analysis of GAPDH mRNA expression in HepG2, Hep 1-6 and Hep-3-B (B) Western blot expression analysis of GAPDH protein under identical conditions in HepG2, Hep 1-6 and Hep-3-B. (C) Semiquantitative RT-PCR analysis of GAPDH mRNA expression in A-549, HT-29 and HCT-116, in vitro (D) Western blot analysis of GAPDH protein expression under identical conditions in A-549, HT-29 and HCT-116. Representative experiments out of three for each experimental set.
Figure 2HIF-1α-mRNA and -protein expression under extreme hypoxic (0.1% O. (A) Semi quantitative RT-PCR analysis of HIF-1α mRNA expression in HepG2, Hep 1-6 and Hep3B (B) Western blot analysis of HIF-1α protein expression under identical conditions in HepG2, Hep 1-6 and Hep3B. (C) Semi quantitative RT-PCR analysis of HIF-1α mRNA expression in A-549, HT-29 and HCT-116, in vitro (D) Western blot analysis of HIF-1α protein under identical conditions in A-549, HT-29 and HCT-116. Representative experiments out of three for each experimental set.
Overview of GAPDH expression in different tumor and non-tumor cell lines as a consequence of the development of a hypoxic cellular microenvironment.
| Malignant glioma cells (Human) | -Apoptosis resistant mutant P53 | [ | [ | ||
| -Peroxisome proliferator activated receptor – γ | |||||
| -PTEN mutation | [ | ||||
| Malignant glioma cells (Human) | [ | [ | |||
| malignant glioma cells (Human) | Mutated p53 | [ | [ | ||
| P14ARF/P16 deletion | |||||
| Chondrocytes (Bovine) | Not determined | [ | |||
| Prostate adenocarcinoma cells | [ | [ | |||
| (Human) | |||||
| Alveolar epithelial cells (Rat) | [ | [ | |||
| Spontaneous cervical cancer cells (Human) | [ | [ | |||
| Wild type p53 | |||||
| Brain capillary endothelial cells | [ | [ | |||
| (Mouse) | |||||
| Endothelial cells (Human) | - Not determined | [ | [ | ||
| - Mutated epithelial cells are present | |||||
| Human Hepatocellular Carcinoma | Raf inactive (-) | [This Paper] | [ | ||
| Wild type p53 | |||||
| Wild type Retinoblastoma | |||||
| Human Hepatocellular Carcinoma | Wild type p53 | [This Paper] | [ | ||
| Absence of RB transcripts | |||||
| Deletion p53 gene | |||||
| Mouse Hepatocellular Carcinoma | - Not determined | [This Paper] | [ | ||
| Colon cancer cell line (Human) | [ | ||||
| Colon cancer cell line (Human) | [ | ||||
| Lung cancer cell line (Human) | [ | ||||